We therefore continued with a 2D proliferation analysis for synergismin five KRAS mutant and dependent cancer cell lineswith diverse levels of PDE6D and PRKG2 dependencies (Figure 5C, Figure S3D). The gene discussed is PDE6D; the disease is cancer.